Lipoxin A4stable analogs reduce allergic airway responsesviamechanisms distinct from CysLT1 receptor antagonism
Open Access
- 11 July 2007
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 21 (14) , 3877-3884
- https://doi.org/10.1096/fj.07-8653com
Abstract
Cellular recruitment during inflammatory/ immune responses is tightly regulated. The ability to dampen inflammation is imperative for prevention of chronic immune responses, as in asthma. Here we inv...Keywords
Funding Information
- National Institutes of Health (HL68669, DE016191, AI0608084, GM38765)
This publication has 36 references indexed in Scilit:
- Lipoxins and aspirin-triggered lipoxin inhibit inflammatory pain processingThe Journal of Experimental Medicine, 2007
- A closer look at chemokines and their role in asthmatic responsesEuropean Journal of Pharmacology, 2006
- Resolution of inflammation: the beginning programs the endNature Immunology, 2005
- New drugs for asthmaNature Reviews Drug Discovery, 2004
- Insights into the Pathogenesis of Asthma Utilizing Murine ModelsInternational Archives of Allergy and Immunology, 2004
- Novel 3-Oxa Lipoxin A4 Analogues with Enhanced Chemical and Metabolic Stability Have Anti-inflammatory Activity in VivoJournal of Medicinal Chemistry, 2004
- AsthmaNew England Journal of Medicine, 2001
- Selectivity of Recombinant Human Leukotriene D4, Leukotriene B4, and Lipoxin A4 Receptors with Aspirin-Triggered 15-epi-LXA4 and Regulation of Vascular and Inflammatory ResponsesThe American Journal of Pathology, 2001
- Oxidoreductases in Lipoxin A4 Metabolic InactivationJournal of Biological Chemistry, 2000
- Design of Lipoxin A4 Stable Analogs That Block Transmigration and Adhesion of Human NeutrophilsBiochemistry, 1995